Publications en collaboration avec des chercheurs de South London and Maudsley NHS Foundation Trust (36)

2024

  1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis

    Molecular Psychiatry

  2. Corrigendum to “Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis” [Psychoneuroendocrinology 150 (2023) 106049] (Psychoneuroendocrinology (2023) 150, (S0306453023000276), (10.1016/j.psyneuen.2023.106049))

    Psychoneuroendocrinology

  3. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies

    Schizophrenia Bulletin, Vol. 50, Núm. 4, pp. 771-783

  4. Number and nature of psychiatric emergency department visits in a tertiary hospital before, during, and after coronavirus pandemic

    Frontiers in Psychiatry, Vol. 15

  5. Prevalence and Correlates of the Concurrence of Autism Spectrum Disorder and Obsessive Compulsive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis

    Brain Sciences, Vol. 14, Núm. 4

  6. Sexually transmitted infections, sexual life and risk behaviours of people living with schizophrenia: Systematic review and meta-Analysis

    BJPsych Open, Vol. 10, Núm. 3

  7. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies

    Translational Psychiatry, Vol. 14, Núm. 1

  8. Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset Psychosis

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 63, Núm. 7, pp. 684-697

  9. What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies

    Psychological Medicine, Vol. 54, Núm. 4, pp. 652-662

2023

  1. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

    Molecular Psychiatry, Vol. 28, Núm. 9, pp. 3671-3687

  2. Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis

    European Psychiatry, Vol. 66, Núm. 1

  3. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review

    European Child and Adolescent Psychiatry

  4. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  5. Neurocognition and functioning in adolescents at clinical high risk for psychosis

    Child and Adolescent Psychiatry and Mental Health, Vol. 17, Núm. 1

  6. Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study

    Frontiers in Psychiatry, Vol. 14

  7. Point of care assay for blood aripiprazole concentrations: Development, validation and utility

    British Journal of Psychiatry, Vol. 223, Núm. 2, pp. 389-393

  8. Predicting bipolar disorder I/II in individuals at clinical high-risk: Results from a systematic review

    Journal of Affective Disorders, Vol. 325, pp. 778-786

  9. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis

    Psychoneuroendocrinology, Vol. 150

  10. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  11. Relationship between elimination disorders and internalizing-externalizing problems in children: A systematic review and meta-analysis

    JCPP Advances, Vol. 3, Núm. 3